Related Experiment Video
Updated: Jul 18, 2026

Changes in Mammary Gland Morphology and Breast Cancer Risk in Rats
Published on: October 16, 2010
Breast-tissue sampling for risk assessment and prevention.
C J Fabian1, B F Kimler, M S Mayo
1Department of Internal Medicine, University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KA 66160, USA. cfabian@kumc.edu
Breast tissue and duct fluid analysis offers key biomarkers for breast cancer risk assessment and prevention. Methods like nipple-aspirate fluid and fine-needle aspiration help identify atypical cells, indicating increased cancer risk.
Area of Science:
- Oncology
- Biomarker Discovery
- Preventive Medicine
Background:
- Breast tissue and duct fluid are valuable sources for breast cancer risk assessment and evaluating prevention interventions.
- Current methods for sampling breast tissue in asymptomatic women include nipple-aspirate fluid (NAF), random periareolar fine-needle aspiration (RPFNA), and ductal lavage.
- Atypical cells found in NAF or RPFNA specimens are linked to a higher breast cancer risk and can further stratify risk using the Gail model.
Purpose of the Study:
- To review methods for sampling breast tissue and duct fluid for breast cancer risk assessment and prevention intervention response.
- To evaluate the utility of various biomarkers, including atypical cells and non-genetic markers, in breast cancer risk stratification.
- To discuss the strengths and weaknesses of different sampling techniques used in breast cancer research.
Main Methods:
- Analysis of nipple-aspirate fluid (NAF) and random periareolar fine-needle aspiration (RPFNA) for atypical cells.
- Utilizing ductal lavage for risk prediction and assessing breast intra-epithelial neoplasia.
- Reviewing established non-genetic biomarkers such as mammographic breast density and serum hormone levels.
Main Results:
- Prospective trials indicate that atypical cells in NAF and RPFNA are associated with increased breast cancer risk.
- RPFNA-detected atypia can further stratify risk within the Gail risk-assessment model.
- Ongoing trials are evaluating risk prediction using ductal lavage fluid and assessing the role of non-genetic biomarkers.
Conclusions:
- Breast fluid and tissue sampling methods provide crucial data for breast cancer risk assessment and prevention.
- Atypical cell detection via NAF and RPFNA is a significant indicator of elevated breast cancer risk.
- Further research is ongoing to define the role of various biomarkers and refine sampling techniques for comprehensive risk evaluation and intervention assessment.
More Related Videos
05:49Use of Magnetic Resonance Imaging and Biopsy Data to Guide Sampling Procedures for Prostate Cancer Biobanking
Published on: October 10, 2019
06:42Optimization of Breast Biopsy and Mastectomy Sample Collection Procedures for Biobanking, Personalized Medicine, and Research Applications
Published on: September 2, 2025